Ensign Peak Advisors, Inc Merck & Co., Inc. Transaction History

Ensign Peak Advisors, Inc

$55.3 Billion
Q4 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 2,671,572 shares of MRK stock, worth $253 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

2,671,572

Previous 3,706,815 27.93%

Holding current value

$253 Million

Previous $421 Million 36.86%

% of portfolio

0.48%

Previous 0.75%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$96.31 - $114.76 $99.7 Million - $119 Million	-1,035,243 Reduced 27.93%	2,671,572 $266 Million
Q3 2024 Nov 14, 2024	SELL	$111.15 - $128.97 $43.6 Million - $50.6 Million	-392,028 Reduced 9.56%	3,706,815 $421 Million
Q2 2024 Aug 13, 2024	SELL	$123.8 - $132.96 $103 Million - $111 Million	-832,195 Reduced 16.88%	4,098,843 $507 Million
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $18.6 Million - $21.7 Million	-164,159 Reduced 3.22%	4,931,038 $651 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $30.4 Million - $33.1 Million	-303,289 Reduced 5.62%	5,095,197 $555 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $12.7 Million - $14.1 Million	122,990 Added 2.33%	5,398,486 $556 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $13 Million - $14.1 Million	-119,276 Reduced 2.21%	5,275,496 $609 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $54.8 Million - $61.1 Million	532,288 Added 10.95%	5,394,772 $574 Million
Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $6.23 Million - $7.98 Million	71,207 Added 1.49%	4,862,484 $539 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $39.7 Million - $44.6 Million	469,758 Added 10.87%	4,791,277 $413 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $197 Million - $224 Million	2,362,744 Added 120.62%	4,321,519 $394 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $39.2 Million - $43.9 Million	532,676 Added 37.35%	1,958,775 $161 Million
Q4 2021 Feb 11, 2022	SELL	$72.28 - $90.54 $95.1 Million - $119 Million	-1,315,527 Reduced 47.98%	1,426,099 $109 Million
Q3 2021 Nov 12, 2021	SELL	$71.68 - $78.83 $15 Million - $16.4 Million	-208,676 Reduced 7.07%	2,741,626 $206 Million
Q2 2021 Aug 13, 2021	SELL	$70.31 - $77.77 $37.3 Million - $41.2 Million	-530,181 Reduced 15.23%	2,950,302 $229 Million
Q1 2021 May 12, 2021	SELL	$68.86 - $81.11 $29.7 Million - $35 Million	-431,732 Reduced 11.04%	3,480,483 $268 Million
Q4 2020 Feb 12, 2021	SELL	$71.77 - $79.65 $16.3 Million - $18 Million	-226,597 Reduced 5.47%	3,912,215 $320 Million
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $40.2 Million - $45.5 Million	-548,961 Reduced 11.71%	4,138,812 $343 Million
Q2 2020 Aug 12, 2020	SELL	$70.42 - $80.13 $35 Million - $39.9 Million	-497,663 Reduced 9.6%	4,687,773 $363 Million
Q1 2020 May 11, 2020	BUY	$63.36 - $87.82 $36.7 Million - $50.8 Million	578,924 Added 12.57%	5,185,436 $399 Million
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $357 Million - $403 Million	4,606,512 New	4,606,512 $419 Million

Others Institutions Holding MRK

# of Institutions

3,970

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $240B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Merck & Co., Inc. Transaction History